These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 223908)
21. [Rabies vaccine inactivated with ethylenimine. Duration of the immunity in dogs]. Larghi OP; Savy VL; Nebel AE; Rodríguez A Rev Argent Microbiol; 1979; 11(3):102-7. PubMed ID: 263180 [TBL] [Abstract][Full Text] [Related]
22. Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process. Pay TW; Boge A; Menard FJ; Radlett PJ Dev Biol Stand; 1985; 60():171-4. PubMed ID: 3899780 [TBL] [Abstract][Full Text] [Related]
23. [Prevention of animal rabies by an attenuated monovalent or mixed vaccine]. Soulebot JP; Précausta P; Brun A; Chappuis G; Terré J; Favre H; Petermann HG Dev Biol Stand; 1978; 41():389-99. PubMed ID: 753667 [TBL] [Abstract][Full Text] [Related]
24. Production and control of rabies vaccines made on diploid cells. Wiktor TJ Dev Biol Stand; 1976 Dec 13-15; 37():265-6. PubMed ID: 1031688 [TBL] [Abstract][Full Text] [Related]
25. [Use of diploid cell lines as a multiplication substrate for viral vaccine production]. Welke G Z Gesamte Hyg; 1980; 26(5):365-72. PubMed ID: 7008390 [No Abstract] [Full Text] [Related]
26. Evaluation of the inactivated tissue culture rabies vaccine from the Vnukovo-32 strain. Results of its industrial production and field use for post-exposure immunization of man. Selimov M; Aksenova T; Klyueva E; Gribencha L; Lebedeva I Dev Biol Stand; 1978; 40():57-62. PubMed ID: 680402 [TBL] [Abstract][Full Text] [Related]
27. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals. Lodmell DL; Esposito JJ; Ewalt LC Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356 [TBL] [Abstract][Full Text] [Related]
28. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV). Lang J; Cetre JC; Picot N; Lanta M; Briantais P; Vital S; Le Mener V; Lutsch C; Rotivel Y Biologicals; 1998 Dec; 26(4):299-308. PubMed ID: 10403033 [TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and efficacy of an in-house developed cell-culture derived veterinarian rabies vaccine. Kallel H; Diouani MF; Loukil H; Trabelsi K; Snoussi MA; Majoul S; Rourou S; Dellagi K Vaccine; 2006 May; 24(22):4856-62. PubMed ID: 16600442 [TBL] [Abstract][Full Text] [Related]
30. A plaque-purified rabies virus (strains V-319) derived from a vampire bat (Desmodus rotundus) in Mexico: vaccine potential. Bijlenga G; Hernandez-Baumgarten EM Cornell Vet; 1984 Apr; 74(2):155-65. PubMed ID: 6467947 [TBL] [Abstract][Full Text] [Related]
31. [Comparison of PVRV and HDCV rabies vaccines as to immunity, reliability and protective value]. Hacibektaşoğlu A; Inal A; Eyigün C; Barut A; Türkay FA Mikrobiyol Bul; 1992 Jan; 26(1):26-36. PubMed ID: 1574019 [TBL] [Abstract][Full Text] [Related]
32. [Potency testing of inactivated rabies vaccines with the antibody binding test in comparison with the NIH and habel test(author's transl)]. Oei HL; Krauss H Zentralbl Bakteriol Orig A; 1975; 231(1-3):1-14. PubMed ID: 1154901 [TBL] [Abstract][Full Text] [Related]
33. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864 [TBL] [Abstract][Full Text] [Related]
34. Studies on an inactivated vaccine against rabies virus in domestic animals. Monaco F; Franchi PM; Lelli R Dev Biol (Basel); 2006; 125():233-9. PubMed ID: 16878481 [TBL] [Abstract][Full Text] [Related]
35. Antibody response to an anti-rabies vaccine in a dog population under field conditions in Bolivia. Suzuki K; González ET; Ascarrunz G; Loza A; Pérez M; Ruiz G; Rojas L; Mancilla K; Pereira JA; Guzman JA; Pecoraro MR Zoonoses Public Health; 2008 Oct; 55(8-10):414-20. PubMed ID: 18399941 [TBL] [Abstract][Full Text] [Related]
36. A comparative study of reactogenicity and immunogenicity of an oral and an inactivated polio vaccine. Borcić B; Dobrovsak-Sourek V; Kaić B; Ljubicić M Acta Med Croatica; 1998; 52(3):155-8. PubMed ID: 9818437 [TBL] [Abstract][Full Text] [Related]
37. Properties of rabies vaccine freed of neuroallergenic factor from brain tissue. Pille ER; Karakuyumchan MK; Nadaichik LV Acta Virol; 1981 Sep; 25(5):304-8. PubMed ID: 6118049 [TBL] [Abstract][Full Text] [Related]
38. Progress with inactivated poliovirus vaccines derived from the Sabin strains. Doi Y; Abe S; Yamamoto H; Horie H; Ohyama H; Satoh K; Tano Y; Ota Y; Miyazawa M; Wakabayashi K; Hashizume S Dev Biol (Basel); 2001; 105():163-9. PubMed ID: 11763324 [TBL] [Abstract][Full Text] [Related]
39. Pre-exposure purified vero cell rabies vaccine and concomitant routine childhood vaccinations: 5-year post-vaccination follow-up study of an infant cohort in Vietnam. Lang J; Feroldi E; Vien NC J Trop Pediatr; 2009 Feb; 55(1):26-31. PubMed ID: 18048461 [TBL] [Abstract][Full Text] [Related]
40. [Zonal centrifuge purification of human rabies vaccine obtained on bovine foetal kidney cells (author's transl)]. Atanasiu P; Tsiang H; Lavergne M; Chermann JC Ann Microbiol (Paris); 1977; 128(2):297-302. PubMed ID: 563208 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]